chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient got very sick; Initial information received on 13-Nov-2020 regarding this unsolicited valid non-serious social media case from a consumer (patient).  This case involves a patient with unknown demographics who got very sick (illness), while the patient received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got very sick (illness) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data was not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown, at the time of reporting.  There will be no information available on the batch number for this case.
(1) At site - right after vaccine - maybe unrelated: slight sinus & nasal congestion for ~ 45 min. However, windows in car open, very windy - could have been normal allergies to whatever was in the wind. Do not know if related. Stopped after closed car window & left. (2) More concern : Ten days after injection 3" diameter, itchy, red rash.  "Covid arm" - Delayed cutaneous hyper-sensitivity". Lasted ~ 36 hours Due to get 2nd shot 2/19 & very scared. (1) For people who get "Covid Arm" with first shot, what happens at and after 2nd shot?  (2) Does having "Covid arm" predispose to worse reaction after 2nd shot or at time of 2nd shot? (3) Why only women getting "Covid Arm?" (4) What is in Moderna that is not in Pfizer, or what is different? This seems only with Moderna. (5) Recommendation for COVID Arm are:      a) Get 2nd dose anyway - but scary as there is no info on this.      b) Get 2nd in other arm, but I had a breast cancer, lumpectomy & one lymph node removed, so I am supposed to avoid shots in other arm. What should I do? Need info on this before 2/19
<24 hours hx redness, swelling around injection site. Low grade fever <24 hours no treatment for fever. Tx: cold compress, infant Tylenol 0.8ml q60 prn.
6 Months after first dose and has not received the second dose; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (6 Months after first dose and has not received the second dose) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (6 Months after first dose and has not received the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (6 Months after first dose and has not received the second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication list was not provided.
PATIENT STATES HAS RACING HEART. VITALS ARE BP 126/67 , HR 72, 100 RESP. SYMPTOMS RESOLVED. PATIENT OBSERVED FOR 15 ADDITIONAL MINS .
buzzing in my ear all day long and its constantly...never goes away. ENT dr recommended Magnesium and B2 vitamins but it never worked.
Felt achy all over; splitting headache day after vaccine. Like I'd been hit by a bus; Exhausted on day 2; rash on both of my lower legs; healing scabbed over rash on both of my lower legs; This is a spontaneous report from a contactable consumer (patient). A 61-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6208, Expiration date not reported), via an unspecified route of administration, administered in left arm on 09Mar2021 11:45 (at the age of 61 years) as dose 2, single for covid-19 immunization. Medical history included known allergies to nickle, ampicillin and Thimerosal. Other medical history was reported as none. The patient's concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EN6201), via an unspecified route of administration, administered in left arm on an unknown date in Feb2021 10:15 (at the age of 61 years) for covid-19 immunization. Patient did not take other vaccine in four weeks and other medications in two weeks of vaccination. Prior to vaccination patient did not have covid and not covid tested post vaccination. On an unknown date, the patient felt achy all over. On an unknown date in Mar2021, patient experienced splitting headache day after vaccine, like she had been hit by a bus, was exhausted on day 2, and on day 3 she noticed a healing scabbed over rash on both of her lower legs. Patient did not receive any treatment for events. The outcome of all the events was recovering.  No follow-up attempts were possible. No further information was expected.
pulsating sensation on left side of the scalp and tingling on the left side of the scalp
Unsure if symptoms child is having were caused by vaccines given.  Per child's mother child noted to have episodes of vomiting, fever last night and today.  Child ref to get up prefers to stay in bed.  Per mother child states her legs hurt.  Alert responsive.  Mother giving TYLENOL since yesterday after vaccines.  Increased heart rate.  ENC.  Mother to take child to ER. for eval.
became extremely ill/sick; is still not well; coughing; chest condition/feels pressure; Chest pain when she coughs/short stinging pain; loss of smell/cannot smell anything; runny nose; diarrhea; chest congestion; fever; maternal exposure during breast feeding; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (became extremely ill/sick), MALAISE (is still not well), COUGH (coughing), CHEST DISCOMFORT (chest condition/feels pressure) and CHEST PAIN (Chest pain when she coughs/short stinging pain) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (became extremely ill/sick), MALAISE (is still not well), COUGH (coughing), CHEST DISCOMFORT (chest condition/feels pressure), CHEST PAIN (Chest pain when she coughs/short stinging pain), ANOSMIA (loss of smell/cannot smell anything), RHINORRHOEA (runny nose), DIARRHOEA (diarrhea), RESPIRATORY TRACT CONGESTION (chest congestion), PYREXIA (fever) and MATERNAL EXPOSURE DURING BREAST FEEDING (maternal exposure during breast feeding). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and IBUPROFEN for Fever, at an unspecified dose and frequency. At the time of the report, ILLNESS (became extremely ill/sick), MALAISE (is still not well), COUGH (coughing), CHEST DISCOMFORT (chest condition/feels pressure), CHEST PAIN (Chest pain when she coughs/short stinging pain), ANOSMIA (loss of smell/cannot smell anything), RHINORRHOEA (runny nose), DIARRHOEA (diarrhea), RESPIRATORY TRACT CONGESTION (chest congestion) and PYREXIA (fever) was resolving and MATERNAL EXPOSURE DURING BREAST FEEDING (maternal exposure during breast feeding) had resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   There was no information regarding ECG, cardiac test, cardiac enzyme. There is no history of COVID-19 infection concomitant medications were not provided. other treatment medications include sinus medication taken for coughing and congestion   This case was linked to MOD-2021-300395 (Parent-Child Link).   See case MOD-2021-300395 for details regarding the child case.
she thought she was going to die; This is a spontaneous report from a contactable consumer (patient's sister). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number was not reported), via an unspecified route of administration on an unspecified date (at an unspecified age) at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced that she thought she was going to die on an unspecified date. She stated she was not sure if she is going to get the second dose. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
This case was reported by a nurse via sales rep and described the occurrence of therapeutic response decreased in a 62-year-old male patient who received ENGERIX B adult (batch number 995J5, expiry date 6th February 2017. This case was associated with a product complaint. Co-suspect products included ENGERIX B adult (batch number 995J5, expiry date 6th February 2017 and ENGERIX B adult (batch number 24JP3, expiry date 10th July 2017. On 7th January 2015, the patient received the 1st dose of ENGERIX B adult. On 4th March 2015, the patient received the 2nd dose of ENGERIX B adult. On 8th July 2015, the patient received the 3rd dose of ENGERIX B adult (intramuscular). On 4th March 2015, not applicable after receiving ENGERIX B adult and ENGERIX B adult, an unknown time after receiving ENGERIX B adult and not applicable after receiving ENGERIX B adult and ENGERIX B adult, the patient experienced drug dose administration interval too long. On 8th July 2015, the patient experienced drug dose administration interval too short. On September 2015, the patient experienced therapeutic response decreased. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the therapeutic response decreased, drug dose administration interval too long, drug dose administration interval too short and pharmaceutical product complaint were unknown. It was unknown if the reporter considered the therapeutic response decreased to be related to ENGERIX B adult, ENGERIX B adult and ENGERIX B adult. Addition details were provided as follows: This case was one of the seven reports reported by an occupational nurse for patients tested negative for Hepatitis B tires following vaccination with ENGERIX B (see cases US2015GSK136759, US2015GSK136758, US2015135763, US2015GSK136760, US2015GSK136761 and US2015GSK136762). The caller reported that, they had their laboratory equipment recalibrated and the tests were rerun and results were same or even lower titers. All the seven patients were new hires at the company and so the reporter was following them. The patients were vaccinated at the same clinic by the complaint reporter or one of her nurses. This case concerned to the patient number 2. On 4th March 2015, the patient received 2nd dose of ENGERIX B adult, which led to lengthening of the vaccination schedule. On 8th July 2015, the patient received 3rd dose of ENGERIX B adult, which led to shortening of the vaccination schedule. On 10th September 2015, 246 days after receiving 1st dose of ENGERIX B adult, 190 days after receiving 2nd dose of ENGERIX B adult and 64 days after receiving 3rd dose of ENGERIX B adult, the patient underwent laboratory test for Hepatitis B antibodies which read as borderline leading to low seroconversion to hepatitis B vaccine.
Pt devel sz disorder after 6 mon DPT shot. Dx w/complex partial sz w/supplementary motor attacks. Tx w/Tegretol
Extremely fatigued (normally patient works at this time); Feverish (never took temp), chills, sweats, dry cough, nausea, whole body aches. Better today.In office Temp 98.2 F (2.5 hours after Tylenol. She has treated with rest, fluids, light diet, Tylenol.  No other symptoms. Appears to be recovering now. Will be seen tomorrow again in follow up.
Circumstance or information capable of leading to medication error; was planning to administer one dose of Bexsero, which could be a potential 3rd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of circumstance or information capable of leading to medication error in a 18-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   Previously administered products included Bexsero (on March 2020 received 1st dose) and Bexsero (on an unknown date received 2nd dose).   On an unknown date, the patient did not receive the 3rd dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced circumstance or information capable of leading to medication error (Verbatim: Circumstance or information capable of leading to medication error) and extra dose administered (Verbatim: was planning to administer one dose of Bexsero, which could be a potential 3rd dose). The outcome of the circumstance or information capable of leading to medication error and extra dose administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 09-JUN-2023 The pharmacist called to inform that a patient that began the scheme of Bexsero back in March 2020 was not sure if the 2nd dose had been received or not due to lack of records. On the day of reporting, the pharmacist was planning to administer one dose, which could be a potential 3rd dose if the 2nd dose had already received and not recorded. On the day of reporting the pharmacist was planning to administer a dose to the patient, which led to extra dose administered and circumstance or information capable of leading to medication error. The reporter did not consent to follow up.
Patient received vaccines at 5 year patient 10/24/07. No calling today to report red, swollen, painful hard area size of baseball left arm. Tylenol for discomfort no itching
pt recv vax 8APR96 & 1996 pt exp negative titer;7FEB97 pt was exposed to a varicella-infected individual & on 19FEB97 pt exp a total of 16 lesions & pruritus;
17 year old was given the vaccine despite 18 years and older being the approved age. Patient's aunt on 3/15/21 reports that patient did not have any side effects from the vaccine. Voice message was left for patient's doctor.
Patient presented with red area on Rt thigh near vaccine site. Area raised, very warm to touch. Patient states sore. Vaccines were administered on Tuesday. Evaluated by Dr. Amoxicillin-clavulanate 400/5mg/5ml 8ml 2 times a day 7day.
Red rash that "tracks" down the arm. There is no pain unless pressure but the rash is warm. The rash has a roughly 8 in diameter.
Headache, Sedation, Myalgia, Fever & NauseaVomiting Narrative:
Blood sugar levels went from 6.7 to 8.7; Diarrhea; Bladder urgency; Triglycerides out of whack; creatine levels went out of whack; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Blood sugar levels went from 6.7 to 8.7), DIARRHOEA (Diarrhea), MICTURITION URGENCY (Bladder urgency), BLOOD TRIGLYCERIDES NORMAL (Triglycerides out of whack) and BLOOD CREATININE ABNORMAL (creatine levels went out of whack) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Surgery (a couple of years ago.). Concurrent medical conditions included Diabetes.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (Blood sugar levels went from 6.7 to 8.7), DIARRHOEA (Diarrhea), MICTURITION URGENCY (Bladder urgency), BLOOD TRIGLYCERIDES NORMAL (Triglycerides out of whack) and BLOOD CREATININE ABNORMAL (creatine levels went out of whack). At the time of the report, BLOOD GLUCOSE INCREASED (Blood sugar levels went from 6.7 to 8.7), DIARRHOEA (Diarrhea), MICTURITION URGENCY (Bladder urgency), BLOOD TRIGLYCERIDES NORMAL (Triglycerides out of whack) and BLOOD CREATININE ABNORMAL (creatine levels went out of whack) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Scan: normal (normal) normal.         No concomitant medication included.  No treatment medication included.
I got my first shot actually felt better but the second shot my arm got very sore around the injection site and then I got deathly sick throwing up for around 8 to 12 hours got very week and dizzy headed and also messed my mind up to where I couldn't think right couldn't hardly walk had to hold onto the wall which I have some problems walking already but that made walking much much more difficult and after that started to feel better and so far I'm still feeling better just wanted to let you know how it done me to see if anyone else has or had any of these symptoms
On 4/19/18 patient received two vaccines in our pharmacy. In his left arm he received SHINGRIX (NDC 58160-0823-11) and his right arm HAVRIX (NDC 58160-0826-43). On 4/22/18 patient came in to show his left arm which was slightly raised, red, swollen and itchy. I told him he can use OTC TYLENOL or ibuprofen and use cold compress on the area. I also told him to follow up with his PCP if the reaction gets any worse. Patient was satisfied with this information.
Fever greater than 102 for over 36 hours - still unresolved.  Vomiting.
I blacked out, felt nauseated, my heart was beating very irradically, unsteady on feet, sudden onset of heat rising from my feet to the top of my head, severe dry mouth, and shortness of breath.
Became dizzy about 10-15 mins after shot, cleared up within 30 min wait.  For next 3 days, extreme muscle and joint pain throughout body (not aches and not at injection site), high fever of 102 with Tylenol, headache, vertigo, nausea, psoriatic joint flare ups, abdominal pain and loose stool.  Day 4 to day 26 low grade fever (99.5-100.3), abdominal pain/loose stool, extreme vertigo & nausea, weight loss, continued joint flare ups and scalp psoriasis, and headache often very sharp on right temple.  Dr prescribed 5 day 10 mg prednisone and vestibular therapy on 7/15.  Short-term improvement of scalp psoriasis & joint pain; pain returned in 3 weeks.  Saw neurologist on 7/29, Dx vestibular migraine.  MRI/MRV normal, no clot.  Prescribed nortriptylene (elevated HR/BP so stopped), prescribed propanolol 10 mg/day - mild & occasional improvement of headache.  8 1/2 weeks after vaccination I still have joint flareups and disabling vertigo & nausea and often headache.  Can't eat, can't do housework, driving makes vertigo worse and need to lay down for up to an hour afterward.  Contacted Dr on 8/8 to request more prednisone.
Developed a rash 5 hours after dose to arms and neck. Continues with itching. Has dark skin where rash was present. Was seen by medical provider and put on 2 medications, but unsure of names.
I received the second Moderna Vaccine 10/17/2021. Around 12:00am experienced severe chills/uncontrollable shaking/severe headache/body aches. This lasted till late in the day 10/19/2021. Now there is a significant red lump that covers the majority of my left upper arm that is hard and feels feverish the injection site. Arm is severely sore and unable to lift over my head. Cannot life items that normally could as like a can of vegatables or my drinking glass. Typing at work today produced significant pain in my left arm in which the vaccine was given. Am experiencing joint pain in my wrist/and finger joints that has not been there prior to this vaccine
Initial healthcare professional report received on 12 Jan 2010: This patient (child under the age of 4 years) received a 0.25 ml IM dose of H1N1 (batch no. 104043P1) on an unspecified date. No adverse effects were noted upon administration.
This case was reported by a consumer via other manufacturer and described the occurrence of passed out in a 64-year-old patient who received Influenza vaccine Quadrivalent unspecified season. On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced passed out (serious criteria GSK medically significant). On an unknown date, the outcome of the passed out was unknown. It was unknown if the reporter considered the passed out to be related to Influenza vaccine Quadrivalent unspecified season. Additional details were provided as follows: The age at vaccination was not reported. The patient passed out after receiving flu shots.
pt recvd vax; devel redness & swelling at inject site; Ice applied to rxn site & all sxs resolved;
Severe diarrhea and some vomiting for 2 days. No relief from diarrhea with over the counter medication. This is the 2nd day of diarrhea and the symptoms are not improving.
Information has been received from a nurse practitioner concerning a 71-year-old female with hypertension, hyperthyroidism, Hyperlipidaemia, migraine and an allergy to pneumococcal vaccine polyvalent (MSD) (WAES # 0806USA00185) and naproxen (ALEVE) who on 02-APR-2008 was vaccinated subcutaneous in the left arm with 0.65 ml dose of zoster vaccine live (Oka/Merck) (lot # 659267/1836U). On 07-APR-2008 the patient developed shingles. The patient had pain and broke out in painful shingles on the left side, T1 dermatome. The patient was seen at her physician's office the same day and was prescribed valacyclovir (VALTREX) and lidocaine transdermal (LIDODERM). At the time of the report the patient's status was unknown. A product quality complaint was not involved. Additional information has been requested.
Muscle pain at site of injection - continuing to today 11/8/2015. Extreme fatigue continuing to today - 11/8/2015. Full blood test panel showed no irregularities.
4 y/o - rt deltoid swelling, warmth, redness 1 day post DTaP - likely DTaP sterile abscess reaction. Motrin/1cc received.